Husch Blackwell successfully defended Sigmapharm Laboratories, LLC in connection with its application for approval of a generic version of the antidepressant vortioxetine.
Erin Knese, Philip Segrest & Steve Holtshouser explore some recent Federal Circuit decisions that clarify venue issues in patent cases.